Which members of Congress traded Bristol Myers Squibb BMY recently?

The latest reported trades: Sen. Tommy Tuberville, full sale on 25/04/15 (reported 08/05), Sen. Alan Armstrong, purchase on 03/27 (reported 07/21), Rep. Mike Kelly, full sale on 05/07 (reported 06/11), Rep. Julie Johnson, full sale on 25/12/18 (reported 01/15) and Rep. Julia Letlow, full sale on 25/04/28 (reported 01/13).

Stocks

Bristol Myers Squibb BMY

Health care sectorNYSE

Close: $62.88; 09/29 close
Day change: −1.6%; vs previous close
Volume: 1,365,240; +94.9% vs 30-day average
52-week range: $42.52$68.59
1-year return: +42.5%; vs the close a year ago
Market cap: $128.4B; 2,042,714,656 shares · reported 07/22

Company

Exchange: NYSE
Sector: Health care
Industry: Pharmaceutical Preparations
Headquarters: Princeton, New Jersey
Fiscal year end: 12/31
Next earnings: 10/29, estimated

Members of Congress reported 2 trades in Bristol Myers Squibb BMY in the past 90 days (1 purchase, 1 sale).

Korean holdings rank: Outside the top 50; Korea Securities Depository · released 09/22
Congress trades: 2; Last 90 days · 1 buys · 1 sales
Insider net buying: No record; Last 90 days · 0 buys · 0 sales
Next earnings: 10/29; Estimated from the last four quarters

Price

$62.88Day −1.6%1 year +42.5%

26-week trading

Common questions

Which members of Congress traded Bristol Myers Squibb BMY recently?: The latest reported trades: Sen. Tommy Tuberville, full sale on 25/04/15 (reported 08/05), Sen. Alan Armstrong, purchase on 03/27 (reported 07/21), Rep. Mike Kelly, full sale on 05/07 (reported 06/11), Rep. Julie Johnson, full sale on 25/12/18 (reported 01/15) and Rep. Julia Letlow, full sale on 25/04/28 (reported 01/13).